Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 3/20 | 0.53 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.44 |
| ▸ | KCNQ3 | O43525 | 3/20 | 0.43 |
| ▸ | KCNQ2 | O43526 | 3/20 | 0.43 |
| ▸ | KCNE1 | P15382 | 3/20 | 0.43 |
| ▸ | KCNQ1 | P51787 | 3/20 | 0.43 |
| ▸ | RORC | P51449 | 2/20 | 0.42 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2534052 | 0.89 | VNN1 (0.54) | VNN1GRM4KCNQ3KCNQ2KCNE1 | |
| SCHEMBL14542864 | 0.76 | KCNQ3 (0.65) | VNN1GRM4KCNQ3KCNQ2KCNE1 | |
| SCHEMBL23486252 | 0.72 | GAA (0.51) | KMT2AL3MBTL1 | |
| SCHEMBL13812239 | 0.71 | LMNA (0.41) | VNN1KCNQ3KCNQ2KCNE1KCNQ1 | |
| SCHEMBL28253118 | 0.70 | S1PR3 (0.46) | VNN1GRM4S1PR3S1PR1MEN1 | |
| SCHEMBL1923606 | 0.69 | PDE4D (0.42) | VNN1GRM4KCNQ3KCNQ2KCNE1 | |
| SCHEMBL20185806 | 0.69 | VNN1 (1.00) | VNN1 | |
| SCHEMBL15867032 | 0.68 | VNN1 (0.56) | VNN1GRM4S1PR3MAPT | |
| SCHEMBL6869441 | 0.67 | S1PR3 (0.52) | S1PR3S1PR1S1PR4S1PR2 | |
| SCHEMBL8129368 | 0.67 | MAPK3 (0.44) | VNN1GRM4S1PR3S1PR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090149452-A1 | XANTHINE OXIDASE INHIBITOR | NIPPON CHEMIPHAR CO., LTD. (JP) | 2009-06-11 | — | — | US | disclosed |
| EP-1911760-A1 | XANTHINE OXIDASE INHIBITOR | Nippon Chemiphar Co., Ltd. (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149452-A1 | XANTHINE OXIDASE INHIBITOR | XDH, PNPO, CBR1 | VNN1 1757/4885GRM4 4605/4885KCNQ3 2704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.